Drug recall · July 10, 2024
Venlafaxine Hydrochloride recall
Why: Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614
- Lots / codes
Lot code: M04614, Exp 09/30/2024
- Quantity
- 864 cartons
- Company
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories, La Vergne, TN
- Distribution
- Nationwide. No foreign consignees.
- Initiated
- June 18, 2024 · Voluntary: Firm initiated
- Classified
- July 3, 2024
- Reported
- July 10, 2024
- Ended
- December 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Venlafaxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.